Author

F. Shi

Institutions: First Affiliated Hospital of Xi'an Jiaotong University, First Hospital of Xi'an, Xi'an Jiaotong University

Observed institutions: First Affiliated Hospital of Xi'an Jiaotong University, First Hospital of Xi'an, Xi'an Jiaotong University

OpenAlex ID: A5111259265

The Recovery of the Absolute Lymphocyte Subpopulation Count in Cervical Cancer Patients after Radiotherapy

2022 · Q. Zhang, J. Zhang, et al. · International Journal of Radiation Oncology*Biology*Physics · 2

616TiP Intra-tumor injection of H101 combined with or without radiotherapy in refractory/recurrent/metastatic gynecological malignancies: A prospective, open-label, multi-center, single-arm study

2022 · Z. Liu, T. Wang, et al. · Annals of Oncology · 1

137P Intra-tumoral recombinant human adenovirus type 5 (H101) in persistent/recurrent/metastatic cervical cancer: Efficacy, safety, and mechanisms via spatial transcriptomics

2025 · Q. Zhang, Z. Liu, et al. · Immuno-Oncology Technology

Exploring Effectiveness and Safety of Nimotuzumab in Recurrent or Metastatic Cervical Cancer

2022 · Z. Liu, J. Zhang, et al. · International Journal of Radiation Oncology*Biology*Physics

The Choice of 2D-Brachytherapy or 3D-Brachytherapy for Cervical Cancer Patients after External Beam Radiation Based on Residual Gross Tumor Volume

2022 · J. Wang, Z. Liu, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 5

Citation count: 3

H-index: 1

I10-index: